Upstate Active Clinical Trials
Study Title:A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant
Upstate Institutional Review Board (IRB) Number:1432147
Patient Age Group:Adults
Principal Investigator:Teresa C Gentile, MD, PhD
What is involved if I participate?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
Where will the study take place?SUNY Upstate Hospital and Cancer Center
Who can I contact for more information?
Name: Corey Chase